MarketPulse

Acumen Pharmaceuticals

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Acumen Pharma Eyes Alzheimer's Breakthrough as Q1 Results Loom

Acumen Pharmaceuticals to report Q1 2026 results May 12, with Phase 2 Alzheimer's drug data expected later this year.
HALOABOSclinical-stage biopharmaceuticalAlzheimer's disease
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Acumen Pharma to Unveil 2025 Results as Alzheimer's Drug Advances

Acumen Pharmaceuticals will report full-year 2025 financial results on March 26, 2026, as its lead Alzheimer's candidate progresses through Phase 2 trials.
HALOABOSPhase 2 clinical trialfinancial results